{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:51:19Z","timestamp":1793670679830,"version":"4.5.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172756"],"award-info":[{"award-number":["82172756"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["22XD1402900"],"award-info":[{"award-number":["22XD1402900"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jtcvs.2023.08.056","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T20:22:35Z","timestamp":1694290955000},"page":"838-847.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Two-year outcomes of clinical N2-3 esophageal squamous cell carcinoma after neoadjuvant chemotherapy and immunotherapy from the phase 2 NICE study"],"prefix":"10.1016","volume":"167","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hezhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bentong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchen","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2023.08.056_bib1","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1245\/s10434-011-2049-9","article-title":"A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907)","volume":"19","author":"Ando","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10388-022-00950-5","article-title":"Comprehensive registry of esophageal cancer in Japan, 2015","volume":"20","author":"Watanabe","year":"2023","journal-title":"Esophagus"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib4","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.21037\/jtd-22-1672","article-title":"Clinical characteristics and survival of esophageal cancer patients: annual report of the surgical treatment in Shanghai Chest Hospital, 2016","volume":"14","author":"Yang","year":"2022","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib5","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/bjs\/znac314","article-title":"Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: multicentre East Asian and Dutch database comparison","volume":"109","author":"Eyck","year":"2022","journal-title":"Br J Surg"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1200\/JCO.2013.51.2186","article-title":"Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials","volume":"32","author":"Oppedijk","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib7","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jtcvs.2009.07.069","article-title":"Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: does the pattern of recurrence differ for patients with complete response and\u00a0those with partial or no response?","volume":"138","author":"Meguid","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(21)01234-4","article-title":"Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study","volume":"398","author":"Sun","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa2111380","article-title":"Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma","volume":"386","author":"Doki","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib10","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/jama.2021.12836","article-title":"Effect of camrelizumab vs placebo added to chemotherapy on survival and progression-free survival in patients with advanced or metastatic esophageal squamous cell carcinoma: the ESCORT-1st randomized clinical trial","volume":"326","author":"Luo","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejca.2020.11.039","article-title":"Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1)","volume":"144","author":"Li","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41392-022-01077-w","article-title":"Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib13","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1158\/1078-0432.CCR-20-4443","article-title":"Neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: a single-arm phase II feasibility trial (PERFECT)","volume":"27","author":"van den Ende","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib14","first-page":"1","article-title":"Japanese classification of esophageal cancer, 11th edition: part I","volume":"14","year":"2017","journal-title":"Esophagus"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib15","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.21037\/atm-20-4991","article-title":"The value of enhanced CT scanning for predicting lymph node metastasis along the right recurrent laryngeal nerve in esophageal squamous cell carcinoma","volume":"8","author":"Li","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib16","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and reliability of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.21147\/j.issn.1000-9604.2019.02.01","article-title":"Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018 (English version)","volume":"31","year":"2019","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib18","first-page":"304","article-title":"Cancer of the esophagus and esophagogastric junction\u2014major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Rice","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib19","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/SLA.0000000000005617","article-title":"CROSS versus FLOT regimens in esophageal and esophagogastric junction adenocarcinoma: a propensity-matched comparison","volume":"276","author":"Donlon","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100613","article-title":"Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma","volume":"7","author":"Petrillo","year":"2022","journal-title":"ESMO Open"},{"issue":"4_suppl","key":"10.1016\/j.jtcvs.2023.08.056_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1200\/JCO.2022.40.4_suppl.238","article-title":"A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study","volume":"40","author":"Kato","year":"2022","journal-title":"Jco"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.annonc.2022.10.508","article-title":"Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial","volume":"34","author":"Tang","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib23","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.20.03614","article-title":"Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial","volume":"39","author":"Eyck","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106767","article-title":"Efficacy and safety of neoadjuvant immunotherapy in surgically resectable esophageal cancer: a systematic review and meta-analysis","volume":"104","author":"Wang","year":"2022","journal-title":"Int J Surg"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jtcvs.2021.11.094","article-title":"Patterns and influence of nodal metastases after neoadjuvant chemoradiation and R0 resection in esophageal adenocarcinoma","volume":"164","author":"Harrington","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib26","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jtcvs.2014.02.008","article-title":"Supraclavicular node metastasis from thoracic esophageal carcinoma: a surgical series from a Japanese multi-institutional nationwide registry of esophageal cancer","volume":"148","author":"Tachimori","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/bjs.1800830134","article-title":"Pattern of recurrence after oesophageal resection for cancer: clinical implications","volume":"83","author":"Law","year":"1996","journal-title":"Br J Surg"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib28","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/SLA.0000000000004329","article-title":"Neoadjuvant\u00a0chemoradiotherapy using cisplatin and 5-fluorouracil (PF) versus carboplatin and paclitaxel (CROSS Regimen) for esophageal squamous cell carcinoma (ESCC): a propensity score-matched Study","volume":"272","author":"Wong","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejca.2020.08.002","article-title":"Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010","volume":"138","author":"Liu","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib30","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1245\/s10434-013-3102-7","article-title":"Different\u00a0recurrence pattern after neoadjuvant chemoradiotherapy compared to\u00a0surgery alone in esophageal cancer patients","volume":"20","author":"Smit","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/bjs.9959","article-title":"Patterns\u00a0of\u00a0recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone","volume":"103","author":"Robb","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/j.semtcvs.2022.04.008","article-title":"Patterns of recurrence after robot-assisted minimally invasive esophagectomy in esophageal squamous cell carcinoma","volume":"35","author":"Yang","year":"2023","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jamcollsurg.2003.10.005","article-title":"Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy","volume":"198","author":"Nakagawa","year":"2004","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib34","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s00595-012-0133-9","article-title":"Patterns and time of recurrence after complete resection of esophageal cancer","volume":"42","author":"Sugiyama","year":"2012","journal-title":"Surg Today"},{"key":"10.1016\/j.jtcvs.2023.08.056_bib35","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1046\/j.1365-2168.2000.01541.x","article-title":"Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy","volume":"87","author":"Dresner","year":"2000","journal-title":"Br J Surg"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522323007821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522323007821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T01:38:12Z","timestamp":1772329092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522323007821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0022522323007821"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2023.08.056","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two-year outcomes of clinical N2-3 esophageal squamous cell carcinoma after neoadjuvant chemotherapy and immunotherapy from the phase 2 NICE study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2023.08.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}